Efficacy and safety of hydroxychloroquine for systemic/cutaneous lupus erythematosus or Sjogren's syndrome patients with annular erythema on the face and/or trunk
Not Applicable
- Conditions
- Systemic/cutaneous lupus erythematosus Sjogren's syndrome
- Registration Number
- JPRN-UMIN000004477
- Lead Sponsor
- Kanazawa University Graduate School of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with current or previous history of retinopathy. 2. Patients unable to take or unsupplied with 4-aminoquinoline. 3. Body weight is less than 30 Kg. 4. History of pregnancy or lactation. 5. Other patients who were judged to be ineligible for the study by an attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of size and/or color of erythematous lesion Patient satisfaction assessed by visual analog scale
- Secondary Outcome Measures
Name Time Method Assessment for safety